Literature DB >> 15688066

p53: traffic cop at the crossroads of DNA repair and recombination.

Sagar Sengupta1, Curtis C Harris.   

Abstract

p53 mutants that lack DNA-binding activities, and therefore, transcriptional activities, are among the most common mutations in human cancer. Recently, a new role for p53 has come to light, as the tumour suppressor also functions in DNA repair and recombination. In cooperation with its function in transcription, the transcription-independent roles of p53 contribute to the control and efficiency of DNA repair and recombination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688066     DOI: 10.1038/nrm1546

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  186 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

Review 2.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

3.  Role of the translationally controlled tumor protein in DNA damage sensing and repair.

Authors:  Jie Zhang; Sonia M de Toledo; Badri N Pandey; Guozheng Guo; Debkumar Pain; Hong Li; Edouard I Azzam
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

4.  Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.

Authors:  Drew D Dudgeon; Sunita N Shinde; Tong Ying Shun; John S Lazo; Christopher J Strock; Kenneth A Giuliano; D Lansing Taylor; Patricia A Johnston; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2010-08       Impact factor: 1.738

5.  Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

6.  Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.

Authors:  Sridharan Rajagopalan; Antonina Andreeva; Trevor J Rutherford; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

Review 7.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

8.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

9.  Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression.

Authors:  Marta Sanchez-Carbayo; Nicholas D Socci; Lee Richstone; Marta Corton; Nille Behrendt; Julia Wulkfuhle; Bernard Bochner; Emmanuel Petricoin; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

10.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.